Berra Yazar-Klosinski, PhD

Dr. Berra Yazar-Klosinski is Chief Development Officer at Freedom Biosciences, where she leads clinical development, regulatory strategy, and translational research across the company’s pipeline of neuropsychiatric therapeutics.

She is a drug development leader with deep expertise in advancing novel neuropsychiatric treatments through late-stage CNS clinical trials and Breakthrough-designated regulatory pathways.